Literature DB >> 32797194

Genetic Variation and Hot Flashes: A Systematic Review.

Carolyn J Crandall1, Allison L Diamant1, Margaret Maglione2, Rebecca C Thurston3, Janet Sinsheimer1.   

Abstract

CONTEXT: Approximately 70% of women report experiencing vasomotor symptoms (VMS, hot flashes and/or night sweats). The etiology of VMS is not clearly understood but may include genetic factors. EVIDENCE ACQUISITION: We searched PubMed and Embase in accordance with the Preferred Reporting Items for Systematic Reviews and Meta-Analyses guidance. We included studies on associations between genetic variation and VMS. We excluded studies focused on medication interventions or prevention or treatment of breast cancer. EVIDENCE SYNTHESIS: Of 202 unique citations, 18 citations met the inclusion criteria. Study sample sizes ranged from 51 to 17 695. Eleven of the 18 studies had fewer than 500 participants; 2 studies had 1000 or more. Overall, statistically significant associations with VMS were found for variants in 14 of the 26 genes assessed in candidate gene studies. The cytochrome P450 family 1 subfamily A member 1 (CYP1B1) gene was the focus of the largest number (n = 7) of studies, but strength and statistical significance of associations of CYP1B1 variants with VMS were inconsistent. A genome-wide association study reported statistically significant associations between 14 single-nucleotide variants in the tachykinin receptor 3 gene and VMS. Heterogeneity across trials regarding VMS measurement methods and effect measures precluded quantitative meta-analysis; there were few studies of each specific genetic variant.
CONCLUSIONS: Genetic variants are associated with VMS. The associations are not limited to variations in sex-steroid metabolism genes. However, studies were few and future studies are needed to confirm and extend these findings. © Endocrine Society 2020. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.

Entities:  

Keywords:  gene; genome-wide association study; hot flashes; menopause; night sweats; vasomotor

Mesh:

Year:  2020        PMID: 32797194      PMCID: PMC7538102          DOI: 10.1210/clinem/dgaa536

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  201 in total

1.  Polymorphism in the CYP2D6 tamoxifen-metabolizing gene influences clinical effect but not hot flashes: data from the Italian Tamoxifen Trial.

Authors:  Bernardo Bonanni; Debora Macis; Patrick Maisonneuve; Harriet A Johansson; Giacomo Gucciardo; Pasquale Oliviero; Roberto Travaglini; Maria G Muraca; Nicole Rotmensz; Umberto Veronesi; Andrea U Decensi
Journal:  J Clin Oncol       Date:  2006-08-01       Impact factor: 44.544

2.  CYP2D6 genotype and tamoxifen response in postmenopausal women with endocrine-responsive breast cancer: the breast international group 1-98 trial.

Authors:  Meredith M Regan; Brian Leyland-Jones; Mark Bouzyk; Olivia Pagani; Weining Tang; Roswitha Kammler; Patrizia Dell'orto; Maria Olivia Biasi; Beat Thürlimann; Maria B Lyng; Henrik J Ditzel; Patrick Neven; Marc Debled; Rudolf Maibach; Karen N Price; Richard D Gelber; Alan S Coates; Aron Goldhirsch; James M Rae; Giuseppe Viale
Journal:  J Natl Cancer Inst       Date:  2012-03-06       Impact factor: 13.506

Review 3.  Hormone Therapy in Breast Cancer Survivors and Those at High Risk for Breast Cancer.

Authors:  Robert L Reid
Journal:  Clin Obstet Gynecol       Date:  2018-09       Impact factor: 2.190

4.  Relationship between apolipoprotein E polymorphism, menopausal symptoms, and serum lipids during hormone replacement therapy.

Authors:  Y Somekawa; A Wakabayashi
Journal:  Eur J Obstet Gynecol Reprod Biol       Date:  1998-08       Impact factor: 2.435

5.  Exploratory study evaluating the association of polymorphisms of angiogenesis genes with hot flashes.

Authors:  Bryan P Schneider; Milan Radovich; David A Flockhart; Janet S Carpenter; Lang Li; Jason D Robarge; Anna M Storniolo; Bradley A Hancock; Todd C Skaar; George W Sledge
Journal:  Breast Cancer Res Treat       Date:  2008-09-11       Impact factor: 4.872

6.  Menopausal complaints in Slovak midlife women and the impact of CYP1B1 polymorphism on their incidence.

Authors:  Lenka Luptáková; Daniela Sivtáková; Veronika Cernanová; Marta Cvicelová
Journal:  Anthropol Anz       Date:  2012

7.  Polymorphisms in Estrogen Synthesis Genes and Symptom Clusters During the Menopausal Transition and Early Postmenopause: Observations From the Seattle Midlife Women's Health Study.

Authors:  Nancy Fugate Woods; Lori A Cray; Ellen Sullivan Mitchell; Fred Farrin; Jerald Herting
Journal:  Biol Res Nurs       Date:  2018-01-15       Impact factor: 2.522

8.  Genetic variants in sex hormone pathways and the risk of type 2 diabetes among African American, Hispanic American, and European American postmenopausal women in the US.

Authors:  Atsushi Goto; Brian H Chen; Kei-Hang K Chan; Cathy Lee; Sarah C Nelson; Andrew Crenshaw; Ebony Bookman; Karen L Margolis; Michèle M Sale; Maggie C Y Ng; Alexander P Reiner; Simin Liu
Journal:  J Diabetes       Date:  2018-04-06       Impact factor: 4.006

9.  Breast cancer susceptibility loci and mammographic density.

Authors:  Rulla M Tamimi; David Cox; Peter Kraft; Graham A Colditz; Susan E Hankinson; David J Hunter
Journal:  Breast Cancer Res       Date:  2008-08-05       Impact factor: 6.466

10.  Genome-wide association to body mass index and waist circumference: the Framingham Heart Study 100K project.

Authors:  Caroline S Fox; Nancy Heard-Costa; L Adrienne Cupples; Josée Dupuis; Ramachandran S Vasan; Larry D Atwood
Journal:  BMC Med Genet       Date:  2007-09-19       Impact factor: 2.103

View more
  1 in total

1.  Genetic variants predictive of reproductive aging are associated with vasomotor symptoms in a multiracial/ethnic cohort.

Authors:  Wei Zhao; Jennifer A Smith; Miao Yu; Carolyn J Crandall; Rebecca C Thurston; Michelle M Hood; Edward Ruiz-Narvaez; Patricia A Peyser; Sharon L R Kardia; Sioban D Harlow
Journal:  Menopause       Date:  2021-04-26       Impact factor: 3.310

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.